Differential effect of HERG blocking agents on cardiac electrical alternans in the guinea pig

Eur J Pharmacol. 2004 Feb 20;486(2):209-21. doi: 10.1016/j.ejphar.2003.12.028.

Abstract

Beat-to-beat alternations of the cardiac monophasic action potential, known as electrical alternans, were studied at drug concentrations that have known arrhythmogenic outcomes. Electrical alternans were elicited from the heart of anesthetized guinea pigs, both in the absence and presence of drugs that inhibit the delayed rectifier K(+) channel encoded by the human ether a-go-go related-gene (HERG), and are associated with the fatal arrhythmia, Torsade de Pointes. Two other HERG inhibiting drugs not associated with Torsade de Pointes were also studied. At concentrations known to be proarrhythmic, E-4031 and bepridil increased mean alternans 10 and 40 ms at pacing frequencies </=160 ms. Terfenadine and cisapride both increased mean alternans up to 20 and 21 ms, respectively, at pacing frequencies of </=150 ms. On the other hand, verapamil and risperidone showed no increase in mean alternans while risperidone significantly reduced alternans at concentrations up to 74 times its therapeutic level. The magnitude of effect on rate-dependent alternans may allow the differentiation of proarrhythmia and non-arrhythmic HERG blockers at clinically relevant concentrations.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Antipsychotic Agents / administration & dosage
  • Antipsychotic Agents / pharmacology
  • Bepridil / administration & dosage
  • Bepridil / pharmacology
  • Blood Pressure / drug effects
  • Calcium Channel Blockers / administration & dosage
  • Calcium Channel Blockers / pharmacology*
  • Calcium Channels, L-Type / drug effects
  • Calcium Channels, L-Type / physiology
  • Cisapride / administration & dosage
  • Cisapride / pharmacology
  • Delayed Rectifier Potassium Channels
  • ERG1 Potassium Channel
  • Ether-A-Go-Go Potassium Channels
  • Gastrointestinal Agents / administration & dosage
  • Gastrointestinal Agents / pharmacology
  • Guinea Pigs
  • Heart Rate / drug effects
  • Histamine H1 Antagonists / administration & dosage
  • Histamine H1 Antagonists / pharmacology
  • Humans
  • In Vitro Techniques
  • Male
  • Myocytes, Cardiac / drug effects
  • Myocytes, Cardiac / physiology
  • Patch-Clamp Techniques
  • Piperidines / administration & dosage
  • Piperidines / pharmacology
  • Potassium Channels, Voltage-Gated / drug effects*
  • Potassium Channels, Voltage-Gated / physiology
  • Pyridines / administration & dosage
  • Pyridines / pharmacology
  • Risperidone / administration & dosage
  • Risperidone / blood
  • Risperidone / pharmacology
  • Terfenadine / administration & dosage
  • Terfenadine / pharmacology
  • Verapamil / administration & dosage
  • Verapamil / blood
  • Verapamil / pharmacology

Substances

  • Antipsychotic Agents
  • Calcium Channel Blockers
  • Calcium Channels, L-Type
  • Delayed Rectifier Potassium Channels
  • ERG1 Potassium Channel
  • Ether-A-Go-Go Potassium Channels
  • Gastrointestinal Agents
  • Histamine H1 Antagonists
  • KCNH2 protein, human
  • Piperidines
  • Potassium Channels, Voltage-Gated
  • Pyridines
  • E 4031
  • Bepridil
  • Terfenadine
  • Verapamil
  • Risperidone
  • Cisapride